As the cruise ship MV Hondius approaches the Granadilla Port in Tenerife, a palpable sense of anxiety is sweeping through local communities. The vessel, which has been the site of a confirmed Andes hantavirus outbreak, is expected to dock soon to facilitate the repatriation of passengers and crew. For many, the sight of an international vessel carrying a known infectious disease evokes the collective trauma of the COVID-19 pandemic.
The situation on board has already seen significant impact. Reports indicate that the virus spread among those on the ship between April and May, resulting in three deaths. A total of 147 individuals—including passengers and crew—are slated to be repatriated to their home countries, which include Germany, France and Australia. The delay in identifying the pathogen added to the mounting tension; it took more than three weeks following the first death for the presence of hantavirus to be officially confirmed on the MV Hondius.
While the instinct toward caution is understandable, medical experts are working to provide a necessary scientific perspective to temper public alarm. The core of the current concern lies in the fear of a highly contagious respiratory outbreak, yet the biological reality of the Andes hantavirus differs fundamentally from the SARS-CoV-2 virus that caused the COVID-19 pandemic.
Addressing the Fear: Why Hantavirus is Not COVID-19
The comparison between hantavirus and coronaviruses is a frequent point of discussion in public health circles during outbreaks. However, the transmission dynamics are vastly different. Unlike the highly efficient airborne spread characteristic of COVID-19, hantaviruses generally require different modes of exposure.
Roman Wölfel, head of the Bundeswehr Institute of Microbiology, has emphasized this distinction.
“Hantaviruses — including the Andes virus — are fundamentally different from coronaviruses,”
Wölfel stated, noting that while these viruses can indeed be transmitted from person to person, the process is “far less easily and only through remarkably close contact.”
the scientific community’s familiarity with the pathogen provides a significant advantage in containment. While the emergence of SARS-CoV-2 in 2019 left healthcare workers and scientists searching for answers regarding its speed and treatment, hantavirus has been a known entity in medical science since 1993. This established knowledge allows for more targeted distancing measures and clinical protocols, as seen in the response to the current situation on the MV Hondius.
The World Health Organization (WHO) has also acknowledged the psychological weight of such news. In a letter addressed to the people of Tenerife on May 9, 2026, WHO Director-General Tedros Adhanom Ghebreyesus addressed the community’s apprehension directly.
“I know that when you hear the word ‘outbreak’ and watch a ship sail toward your shores, memories surface that none of us have fully put to rest,”
Tedros wrote, recognizing the lingering global anxiety regarding international disease transmission.
Understanding the Andes Virus and HPS
To understand the risks, one must distinguish between the various types of hantaviruses. Most hantaviruses are rodent-borne, transmitted through contact with the urine, droppings, or saliva of infected animals like rats and mice. However, the Andes virus is unique within the hantavirus family as the only type known to facilitate person-to-person transmission, though this remains limited to those in very close proximity to an infected individual.
In the Western Hemisphere, hantavirus infections often manifest as Hantavirus Pulmonary Syndrome (HPS), a severe respiratory disease. According to the Centers for Disease Control and Prevention (CDC), HPS is a potentially deadly condition that primarily affects the lungs. While Hantavirus Pulmonary Syndrome is the primary concern in the Americas, other forms of the virus, such as Hemorrhagic Fever with Renal Syndrome (HFRS), are more commonly found in Europe and Asia.
Clinical Progression and Symptoms
Recognizing the symptoms of HPS is critical for early intervention. The illness typically progresses in two distinct phases:
- The Initial Phase: Symptoms usually appear between 1 to 8 weeks after exposure. Early signs include fatigue, fever, and significant muscle aches, particularly in large muscle groups such as the thighs, hips, back, and shoulders.
- Secondary Symptoms: Approximately half of all HPS patients also experience headaches, dizziness, chills, and abdominal issues such as nausea, vomiting, diarrhea, and abdominal pain.
- The Late Phase: Approximately four to 10 days after the initial symptoms appear, the disease can progress to more severe respiratory distress, characterized by coughing and shortness of breath.
Because of this progression, healthcare providers prioritize monitoring those who have had close contact with confirmed cases to manage the transition from the initial febrile stage to the critical respiratory stage.
Comparison: Andes Hantavirus vs. SARS-CoV-2
For a clearer understanding of why public health officials are managing this differently than previous pandemics, the following table summarizes the primary differences in transmission and context.
| Feature | Andes Hantavirus | SARS-CoV-2 (COVID-19) |
|---|---|---|
| Primary Transmission | Rodent contact; limited person-to-person via close contact | Highly contagious respiratory droplets/aerosols |
| Ease of Spread | Relatively tough; requires close proximity | Extremely easy; widespread community spread |
| Scientific Knowledge | Known since 1993 | Novel pathogen (emerged 2019) |
| Primary Clinical Concern | Hantavirus Pulmonary Syndrome (HPS) | Systemic respiratory and multi-organ involvement |
What Happens Next?
The immediate focus for health authorities remains the safe handling of the 147 individuals currently on the MV Hondius. The logistical priority is the orderly repatriation of passengers and crew to Germany, France, and Australia, ensuring that all individuals undergo necessary medical screening and monitoring to prevent any further localized spread.
Public health officials continue to monitor the situation at Granadilla Port. While the risk to the general public in Tenerife remains low due to the specific transmission requirements of the Andes virus, the implementation of appropriate distancing and hygiene protocols remains the standard procedure for managing any reported outbreak.
Next Checkpoint: Official updates regarding the completion of the repatriation process and the final health assessments of the passengers are expected following the ship’s docking at Granadilla Port.
Have thoughts on how international health protocols should handle cruise ship outbreaks? Share your views in the comments below and share this article to keep your community informed.